http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103923002-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0152623cff45c7c58e9c47b65ea4ca
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-227
filingDate 2014-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f6e4ad8ecff903f26acf0e1993077e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0a5d71ae49551c2576adfce5dbe849b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d425527f3f65736efbb82d0e3388fc95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8381590148e97ca4381c4a03957706c
publicationDate 2014-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103923002-A
titleOfInvention A kind of preparation method of aripiprazole intermediate
abstract An improved preparation method of aripiprazole intermediate 7-(4-bromobutoxy)-3,4-dihydroquinolone, which includes in alcohol solvent, 3,4-dihydro-7- Hydroxy-2(1H)-quinolinone reacts with 1,4-dibromobutane under the catalysis of base in the presence of polyethylene glycol (PEG). The reaction yield of the invention is over 90%, the high-performance liquid phase (HPLC) purity of the product is over 93%, the reaction time is short, the energy consumption is low, the solvent recovery is convenient, and the cost can be reduced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111624263-A
priorityDate 2013-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007148191-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010012121-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426160588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10542064

Total number of triples: 19.